Coronavirus Treatment Acceleration Program

April 2, 2020 by Mandy Qualls

Filed under Recruitment & Volunteers

Last modified April 6, 2020

The U.S. Food and Drug Administration is fast-tracking drugs to treat COVID-19.

The Coronavirus Treatment Acceleration Program is designed to bring new therapies to COVID-19 patients as quickly as possible while supporting research to determine whether those therapies are safe and effective. The agency said that it was reviewing study protocols within 24 hours in many cases and reviewing expanded access requests within three hours. Read more from Modern Healthcare.

Share this

Related Articles

                                  Leave a Comment